Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
Aims to achieve CDMO sales of US$ 400 million by 2028
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
CMOs showed an increasing reluctance to take on debt in 2022
Subscribe To Our Newsletter & Stay Updated
